|
Mar 12
|
Smith & Nephew Full Year 2024 Earnings: EPS Misses Expectations
|
|
Mar 11
|
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
|
|
Mar 10
|
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
|
|
Mar 6
|
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
|
|
Mar 6
|
Be Wary Of Smith & Nephew (LON:SN.) And Its Returns On Capital
|
|
Mar 5
|
Smith & Nephew opens door to break-up in response to activist, The Times says
|
|
Mar 4
|
Smith+Nephew is pioneering Spatial Surgery – a defining new Sports Medicine category pushing the boundaries of technology and procedural innovation
|
|
Feb 25
|
Trending tickers: Tesla, Palantir, Alibaba, Unilever and bitcoin
|
|
Feb 25
|
Hip replacement firm Smith & Nephew’s profit surges amid recovery in US sales
|
|
Feb 21
|
Stocks to watch next week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin
|
|
Feb 17
|
3 UK Stocks That May Be Undervalued By The Market
|
|
Feb 16
|
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
|
|
Feb 12
|
Smith & Nephew plc (SNN) Among the 10 Safest Dividend Stocks in the UK
|
|
Jan 14
|
Smith+Nephew’s ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable’ Evidence Bar™ ratings from ECRI for pressure injury prevention
|
|
Jan 14
|
3 UK Stocks Trading At Up To 41% Below Intrinsic Value Estimates
|
|
Jan 2
|
Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 39%?
|
|
Dec 30
|
Is Smith & Nephew plc (SNN) Among the U.K. Dividend Champions for 2024?
|
|
Dec 29
|
Is Smith & Nephew plc (SNN) Among the U.K. Dividend Aristocrats for 2024?
|
|
Oct 9
|
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
|
|
Sep 30
|
September 2024's UK Stock Picks For Possible Value Investing
|